NCT04045548View on ClinicalTrials.gov

Vaginal Dinoprostone Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System in Women With no Previous Vaginal Delivery

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

August 10, 2019

Primary Completion Date

January 1, 2020

Study Completion Date

January 5, 2020

Conditions

Intrauterine Device

Interventions

DRUG

Dinoprostone

1 vaginal tablet of dinoprostone (3mg) (prostin® E2, Pharmacia \& Upjohn, Puurs, Belgium) inserted by the study nurse 6 hours before IUD insertion.

DRUG

Placebo

one tablet of placebo inserted by the study nurse 6 hours before IUD insertion.

Trial Locations (1)

11231

faculty of medicine Cairo university, Cairo

All Listed Sponsors

lead

Cairo University

OTHER

NCT04045548 - Vaginal Dinoprostone Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System in Women With no Previous Vaginal Delivery | Biotech Hunter | Biotech Hunter